ProQR Therapeutics N.V. - PRQR

About Gravity Analytica
Recent News
- 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
- 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
- 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
- 05.08.2025 - ProQR Announces First Quarter 2025 Operating and Financial Results
- 05.08.2025 - ProQR Announces First Quarter 2025 Operating and Financial Results
- 05.02.2025 - ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
- 05.01.2025 - ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
- 04.14.2025 - ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
- 03.13.2025 - ProQR Announces Year End 2024 Operating and Financial Results
- 03.13.2025 - ProQR Announces Year End 2024 Operating and Financial Results
Recent Filings
- 05.08.2025 - EX-99.1 EX-99.1
- 05.08.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 05.01.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 05.01.2025 - EX-99.1 EX-99.1
- 04.14.2025 - EX-99.1 EX-99.1
- 04.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 03.25.2025 - EFFECT Notice of Effectiveness
- 03.25.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 03.21.2025 - CORRESP Correspondence
- 03.20.2025 - UPLOAD SEC-generated letter